Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Clinical trial NCT01077154 · TERMINATED
Trial details
- NCT number
- NCT01077154
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-02
- Primary completion
- 2017-08-31
- Enrollment
- 4509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.